These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7013405)

  • 1. [Pharmacology of oral cholecystography].
    Gaón D
    Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral cholecystography with iopanoic acid.
    Berk RN; Loeb PM; Goldberger LE; Sokoloff J
    N Engl J Med; 1974 Jan; 290(4):204-10. PubMed ID: 4587633
    [No Abstract]   [Full Text] [Related]  

  • 3. Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs.
    Hunter TB; Fon GT; Berk RN; Capp MP
    Gastrointest Radiol; 1981; 6(4):349-52. PubMed ID: 7308718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and physiology of the biliary radiographic contrast materials.
    Berk RN; Loeb PM
    Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors in the intestinal absorption of oral cholecystopaques.
    Amberg JR; Thompson WM; Golberger L; Williamson S; Alexander R; Bates M
    Invest Radiol; 1980; 15(6 Suppl):S136-41. PubMed ID: 7203915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic excretion of cholecystopaques introduced into the canine jejunum.
    Menuck L; Amberg JR; Bates M
    Invest Radiol; 1977; 12(1):106-8. PubMed ID: 138663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual contrast medium in the bowel in cholecystography with iopanoic acid and certain related substances.
    ANDREN L; THEANDER G
    Acta Radiol (Stockh); 1960 May; 53():371-6. PubMed ID: 13793563
    [No Abstract]   [Full Text] [Related]  

  • 13. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oral cholecystopaques: iopronic acid vs. iopanoic acid.
    Amberg JR; Goldberger LA; Bates M
    Radiology; 1980 Jan; 134(1):31-2. PubMed ID: 6985742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of secretin on the hepatic excretion of telepaque.
    Berk RN; Dunn CR
    Radiology; 1972 Jun; 103(3):585-7. PubMed ID: 5022955
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal cortical slice accumulation of iophenoxic acid and iopanoic acid.
    Berndt WO; Wade DN; Mudge GH
    J Pharmacol Exp Ther; 1971 Oct; 179(1):74-84. PubMed ID: 5096566
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption of iopanoic acid and its sodium salt.
    HOLMDAHL KH SON ; LODIN H
    Acta Radiol (Stockh); 1959 Apr; 51(4):247-50. PubMed ID: 13649372
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium tyropanoate, a new oral cholecystographic agent.
    Hoppe JO; Ackerman JH; Larsen AA; Moss J
    J Med Chem; 1970 Sep; 13(5):997-9. PubMed ID: 5458405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.